Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 17Neoplasm Metastasis 3Obesity 2Arthralgia 2Vitamin D Deficiency 1Recurrence 1Post Menopausal Women With Early Breast Cancer 1Pain 1Nutrition Disorders 1Multiple Endocrine Neoplasia Type 1 1Invasive Early Breast Cancer 1Carcinoma, Intraductal, Noninfiltrating 1Breast Cancer Organoids 1

Interventions

Surveys and Questionnaires 8Psychiatric Rehabilitation 6Fentanyl 4Interviews as Topic 3Therapeutics 2Oxycodone 2Mental Status and Dementia Tests 2Analgesics, Opioid 2ziprasidone 1radium Ra 223 dichloride 1pegfilgrastim 1exemestane 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Urinary Catheterization 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sevelamer 1Ropivacaine 1Rocuronium 1Restraint, Physical 1Rehabilitation 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Quality of Life 1Plastic Surgery Procedures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Pain × exemestane × Clear all
NCT01814397 2024-02-07

Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients

University of Michigan Rogel Cancer Center

Completed
50 enrolled 15 charts
Breast

Breast Neoplasms, Pain, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡